SERP
Comments:
BI-1950 has both strong binding affinity to the target protein LFA1 and potent activity in IL-2 cellular assays using both PBMCs and whole blood. The plasma protein binding is high, so this should be considered when serum/albumin is present in assay media. There is a strong data pack around selectivity which indicates that no concerning off-target activity has been identified.
When considering the use of BI-1950 in rodent efficacy models it is important to take into consideration 250-fold weaker activity in IL-2 assays using mouse splenocytes compared with human PBMCs. Although the PK parameters have been disclosed, I do not believe that total or free drug levels have been shared which would be useful.
(last updated:
11 Mar 2022 )